120
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Orbital Sarcoidosis in a High TB Endemic Country – A Case Series from South India

, MRCOphth (Lon), MAMS, , MS & , MSORCID Icon
Pages 957-962 | Received 16 Oct 2019, Accepted 17 Dec 2019, Published online: 19 Feb 2020
 

ABSTRACT

Aim: We report a series of orbital sarcoid in a south Indian patient population and their outcome.

Materials & Methods: Retrospective interventional case series.

Results: Eleven out of 144cases of biopsy-proven sarcoidosis had orbital involvement. The mean age was 50.64 ± 9.52years and was more commonly seen in women (90.91%). Unilateral presentation with right orbit involvement was more common. Bilateral lacrimal gland enlargement (4cases), inferior orbital mass presenting as proptosis (4cases), preseptal mass above upper eyelid (2cases) and orbital mass encasing the globe (1case) were the different types of orbital presentation. All cases had a dry eye and a negative mantoux test. CT thorax was abnormal in 7cases (63.61%). Biopsy in all cases showed noncaseating granulomatous inflammation. Oral steroids were the standard mode of treatment and none of the cases had recurrences.

Conclusions: Orbital sarcoidosis is seen in a high TB endemic country like India and is definitely underreported.

Declaration of Interest Statement

The authors have no financial interest in the study

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.